{
  "meta": {
    "title": "15_Diabetes_Mellitus_Complications_And_Their_Management",
    "url": "https://brainandscalpel.vercel.app/15-diabetes-mellitus-complications-and-their-management-0f2e6f51.html",
    "scrapedAt": "2025-11-30T12:28:25.779Z"
  },
  "questions": [
    {
      "text": "Which of the following is not a feature of diabetic ketoacidosis?",
      "choices": [
        {
          "id": 1,
          "text": "Low serum sodium"
        },
        {
          "id": 2,
          "text": "High anion gap"
        },
        {
          "id": 3,
          "text": "Serum pH is  < 7.4"
        },
        {
          "id": 4,
          "text": "Serum bicarbonate  > 15 meq/L"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In diabetic ketoacidosis (DKA), serum <strong>bicarbonate</strong> is usually &lt;<strong> 15. </strong>Serum HCO3 &gt; 15 meq/L is suggestive of alcoholic ketoacidosis. </p>\n<p>DKA is an <strong>acute</strong> complication of <strong>type 1 </strong>diabetes mellitus. It is usually precipitated by absolute or relative <strong>insulin</strong> <strong>deficiency</strong> caused by increased metabolic demand (infections) or insulin noncompliance.</p>\n<p>The common symptoms include nausea, vomiting, and severe abdominal pain. The common signs include <strong>Kussmaul</strong> breathing, <strong>f</strong><strong>ruity odor</strong> of the <strong>breath,</strong> dehydration, tachycardia, hypotension, and delirium.</p>\n<p>The diagnosis of <strong>DKA</strong> is made based on the following parameters:</p>\n<ul>\n<li>Hyperglycemia <strong>&gt; 250 mg/dl</strong></li>\n<li><strong>Ketosis</strong> or ketones in urine</li>\n<li>Metabolic acidosis with <strong>pH &lt; 7.3</strong></li>\n<li><strong>HCO3 &lt; 15-18</strong> mEq/L</li>\n<li><strong>High anion gap</strong> due to ketoacids and lactic acidosis</li>\n</ul>\n<p><strong>Hyponatremia</strong> is seen as a result of <strong>hyperglycemia</strong> (osmotic shift causes dilutional hyponatremia). Normal sodium levels on admission indicate severe dehydration. Despite a total-body potassium deficit, the serum <strong>Potassium</strong> at presentation may be mildly elevated, secondary to the acidosis and volume depletion.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7066",
      "difficulty": "easy"
    },
    {
      "text": "A 19-year-old woman with a history of type 1 diabetes is brought to the ER with confusion, vomiting, and abdominal pain. Investigations show blood glucose of 520 mg/dl and urine positive for ketone bodies. Which of the following is the drug of choice?",
      "choices": [
        {
          "id": 1,
          "text": "Regular insulin"
        },
        {
          "id": 2,
          "text": "Lente insulin"
        },
        {
          "id": 3,
          "text": "Insulin glargine"
        },
        {
          "id": 4,
          "text": "70/30 insulin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The drug of choice for controlling <strong>hyperglycemia</strong> in a patient with <strong>diabetic ketoacidosis</strong> (DKA) is <strong>short-acting insulin,</strong> preferably <strong>regular insulin.</strong></p>\n<p>Intermediate (such as lente insulin and NPH), long-acting insulins, and oral hypoglycemic agents are never used in the&nbsp;initial management of DKA.&nbsp;</p>\n<p>The mainstay of treatment is the administration of <strong>normal saline</strong> followed by <strong>infusion</strong> of short-acting <strong>insulin</strong>. The precipitating event must be identified and treated. Careful <strong>monitoring</strong> of&nbsp;<strong>K<sup>+</sup>&nbsp;levels</strong> and replacement in the later stages is required, as insulin therapy causes hypokalemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7069",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the leading cause of death in children with diabetic ketoacidosis?",
      "choices": [
        {
          "id": 1,
          "text": "Acute respiratory distress syndrome"
        },
        {
          "id": 2,
          "text": "Cardiac arrhythmia"
        },
        {
          "id": 3,
          "text": "Cerebral edema"
        },
        {
          "id": 4,
          "text": "Acute kidney injury"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cerebral edema</strong> is the leading cause of <strong>mortality</strong> in children with&nbsp;<strong>diabetic ketoacidosis</strong>.</p>\n<p>The <strong>osmolar gradient</strong> generated due to the high blood glucose level results in <strong>water shift</strong> from the intracellular fluid (ICF) to the extracellular fluid (ECF) space and leads to the <strong>contraction</strong> of <strong>cell volume</strong>. Correction with insulin and intravenous fluids can result in a rapid reduction in effective osmolarity, reversal of the fluid shift, and result in cerebral edema.</p>\n<p>Complications of diabetic ketoacidosis include:</p>\n<ul>\n<li>Cerebral edema &ndash; especially in children</li>\n<li><strong>Cardiac arrhythmia</strong> - due to electrolyte imbalance</li>\n<li>Acute respiratory distress syndrome (<strong>ARDS</strong>)</li>\n<li>Venous thrombosis</li>\n<li>Acute gastric dilation</li>\n<li><strong>Acute kidney injury&nbsp;</strong></li>\n<li>Intestinal necrosis</li>\n<li>Acute pancreatitis</li>\n<li>Mucormycosis</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7072",
      "difficulty": "medium"
    },
    {
      "text": "A patient with diabetic ketoacidosis has severe abdominal pain. Which of the following is the recommended test to rule out acute pancreatitis?",
      "choices": [
        {
          "id": 1,
          "text": "Lipase"
        },
        {
          "id": 2,
          "text": "Elastase"
        },
        {
          "id": 3,
          "text": "Amylase"
        },
        {
          "id": 4,
          "text": "Trypsinogen"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In diabetic ketoacidosis (<strong>DKA</strong>), severe abdominal pain can mimic <strong>acute pancreatitis.</strong>&nbsp;Serum<strong> lipase</strong> is the best test to rule out this condition. It must then be confirmed by imaging (USG or CT abdomen).</p>\n<p>Serum <strong>amylase</strong> is an <strong>unreliable</strong> indicator as DKA<strong>&nbsp;</strong>is associated with hyperamylasemia&nbsp;of <strong>salivary</strong> origin.</p>\n<p>Serum and urine trypsinogen may be elevated in early pancreatitis but are not used for diagnosis. Fecal elastase is elevated in chronic pancreatitis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7073",
      "difficulty": "medium"
    },
    {
      "text": "A 15-year old boy presents with persistent vomiting for one day. Laboratory investigations reveal the following. What is the best sequence of management?<div class='question-desc-html'><p>Random blood glucose: 400 mg/dl</p>\n<p>Serum sodium: 133 mEq/L</p>\n<p>Serum potassium: 3 mEq/L</p>\n<p>Urine ketone bodies: 4+</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Start IV fluids, administer IV regular insulin, and then correct hypokalemia"
        },
        {
          "id": 2,
          "text": "Start IV fluids, administer subcutaneous bolus of insulin and correct hypokalemia concurrently"
        },
        {
          "id": 3,
          "text": "Start IV fluids and correct hypokalemia first, then administer IV regular insulin"
        },
        {
          "id": 4,
          "text": "Administer IV regular insulin with KCl first , then start IV fluids once the K+ level is corrected"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This clinical scenario is suggestive of diabetic ketoacidosis (DKA). On confirming the diagnosis, <strong>IV fluids</strong> must be started. If the initial serum <strong>potassium</strong> <strong>&lt; 3.3 meq/L</strong>, insulin should be administered only after the <strong>correction </strong>of hypokalemia.</p>\n<p>This is because treatment with <strong>insulin</strong> and fluids can <strong>worsen hypokalemia </strong>by the following mechanisms:</p>\n<ul>\n<li><strong>Insulin</strong> causes the shift of K<sup>+</sup> ions into cells</li>\n<li><strong>Resolution</strong> of the <strong>acidosis</strong> also promotes K<sup>+</sup> entry into cells</li>\n<li><strong>Urinary loss</strong> of K<sup>+</sup> salts of organic acids</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d57dbb1b28fa4a118652e49c9db3ad8cx1280x2461.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7076",
      "difficulty": "medium"
    },
    {
      "text": "Distinguishing features between hyperglycemic hyperosmolar state and diabetic ketoacidosis include all  of the following except:",
      "choices": [
        {
          "id": 1,
          "text": "Ketosis"
        },
        {
          "id": 2,
          "text": "Anion gap"
        },
        {
          "id": 3,
          "text": "Hypotension"
        },
        {
          "id": 4,
          "text": "Arterial pCO2"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hypotension </strong>and<strong> tachycardia</strong> are&nbsp;<strong>common features</strong>&nbsp;of both&nbsp;hyperglycemic hyperosmolar state (HHS) and diabetic ketoacidosis (DKA).</p>\n<p>In DKA, insulin deficiency and an increase in counter-regulatory hormones lead to shunting of free fatty acids to form ketone bodies. The ketoacids increase the anion gap and cause low pH. In <strong>HHS</strong>, there is still some insulin available. Hence, there are <strong>no ketones</strong> formed, and the patient has&nbsp;<strong>normal pH</strong> and <strong>pCO2</strong>.</p><hr><h3>Related Pearl: Comparative Features of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>DKA</strong></p>\n</td>\n<td>\n<p><strong>HHS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Seen in </strong></p>\n</td>\n<td>\n<p>Type 1 DM</p>\n</td>\n<td>\n<p>Type 2 DM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n<td>\n<p>Abdominal pain</p>\n<p>Kussmaul respiration</p>\n<p>Fruity odour of breath</p>\n</td>\n<td>\n<p>Altered sensorium</p>\n<p>Coma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glucose (mg/dL)</strong></p>\n</td>\n<td>\n<p>250&ndash;600</p>\n</td>\n<td>\n<p>600&ndash;1200</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sodium</strong></p>\n</td>\n<td>\n<p>120&ndash;125</p>\n</td>\n<td>\n<p>135&ndash;145</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Osmolality </strong></p>\n</td>\n<td>\n<p>300&ndash;320</p>\n</td>\n<td>\n<p>330&ndash;380</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasma Ketones</strong></p>\n</td>\n<td>\n<p>++++</p>\n</td>\n<td>\n<p>+/-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum Bicarbonate</strong></p>\n</td>\n<td>\n<p>&lt; 15 meq/ L</p>\n</td>\n<td>\n<p>Normal to slightly &darr;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pH </strong></p>\n</td>\n<td>\n<p>6.8&ndash;7.3</p>\n</td>\n<td>\n<p>&gt;7.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pCO<sub>2 </sub>(mmHg)</strong></p>\n</td>\n<td>\n<p>20&ndash;30</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anion Gap</strong></p>\n</td>\n<td>\n<p><strong>&uarr;</strong></p>\n</td>\n<td>\n<p>Normal to slightly &uarr;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7079",
      "difficulty": "medium"
    },
    {
      "text": "An elderly man is brought to the hospital with confusion and drowsiness. His son says that he has been urinating more frequently than normal and eating very little over the past 1 week. Capillary blood glucose is 800 mg/dl.  Which of the following would not be seen in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Serum osmolality > 350 mOsm/L"
        },
        {
          "id": 2,
          "text": "Normal pH"
        },
        {
          "id": 3,
          "text": "Kussmaul breathing"
        },
        {
          "id": 4,
          "text": "Prerenal azotemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This clinical scenario is suggestive of&nbsp;<strong>hyperglycemic hyperosmolar state </strong>(HHS).&nbsp;Kussmaul's breathing is not a feature of HHS.</p>\n<p>HHS is commonly seen in <strong>older</strong> adults suffering from <strong>type 2 </strong>diabetes mellitus. Patients can present with the following features:</p>\n<ul>\n<li><strong>Polyuria</strong></li>\n<li>Polydipsia</li>\n<li>Lethargy&nbsp;</li>\n<li><strong>Altered sensorium</strong>, coma</li>\n<li>Seizures</li>\n<li>Severe dehydration</li>\n</ul>\n<p>The following lab values are seen:&nbsp;</p>\n<ul>\n<li>Blood glucose of <strong>600-1200</strong> mg/dl</li>\n<li>Serum <strong>osmolality</strong> &gt; <strong>350</strong> mOsm/L</li>\n<li><strong>Prerenal azotemia</strong>&nbsp;due to dehydration</li>\n<li>Pseudohyponatremia&nbsp;may be seen due to hyperglycemia</li>\n<li>Normal pH and ketones</li>\n</ul>\n<p>The mainstay of management is <strong>fluid</strong> replacement, IV regular <strong>insulin</strong>, along with <strong>potassium</strong> replacement.</p>\n<p><strong>Heparin</strong> can be given <strong>prophylactically</strong> as volume contraction can increase the&nbsp;<strong>risk of venous thrombosis</strong>.</p><hr><h3>Related Pearl: Comparative Features of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>DKA</strong></p>\n</td>\n<td>\n<p><strong>HHS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Seen in </strong></p>\n</td>\n<td>\n<p>Type 1 DM</p>\n</td>\n<td>\n<p>Type 2 DM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n<td>\n<p>Abdominal pain</p>\n<p>Kussmaul respiration</p>\n<p>Fruity odour of breath</p>\n</td>\n<td>\n<p>Altered sensorium</p>\n<p>Coma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glucose (mg/dL)</strong></p>\n</td>\n<td>\n<p>250&ndash;600</p>\n</td>\n<td>\n<p>600&ndash;1200</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sodium</strong></p>\n</td>\n<td>\n<p>120&ndash;125</p>\n</td>\n<td>\n<p>135&ndash;145</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Osmolality </strong></p>\n</td>\n<td>\n<p>300&ndash;320</p>\n</td>\n<td>\n<p>330&ndash;380</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasma Ketones</strong></p>\n</td>\n<td>\n<p>++++</p>\n</td>\n<td>\n<p>+/-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum Bicarbonate</strong></p>\n</td>\n<td>\n<p>&lt; 15 meq/ L</p>\n</td>\n<td>\n<p>Normal to slightly &darr;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pH </strong></p>\n</td>\n<td>\n<p>6.8&ndash;7.3</p>\n</td>\n<td>\n<p>&gt;7.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pCO<sub>2 </sub>(mmHg)</strong></p>\n</td>\n<td>\n<p>20&ndash;30</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anion Gap</strong></p>\n</td>\n<td>\n<p><strong>&uarr;</strong></p>\n</td>\n<td>\n<p>Normal to slightly &uarr;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7078",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common pattern of dyslipidemia associated with diabetes mellitus?",
      "choices": [
        {
          "id": 1,
          "text": "Increased triglycerides and decreased HDL"
        },
        {
          "id": 2,
          "text": "Increased LDL and decreased HDL"
        },
        {
          "id": 3,
          "text": "Increased VLDL and decreased HDL"
        },
        {
          "id": 4,
          "text": "Increased triglycerides and increased VLDL"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Dyslipidemia </strong>commonly occurs as a complication of <strong>type 2 diabetes mellitus</strong>. The most common pattern is as follows:</p>\n<ul>\n<li><strong>Increased triglyceride</strong> levels - due to increased glucose and free fatty acids, decreased lipolysis of VLDL.</li>\n<li><strong>Decreased HDL</strong> levels</li>\n</ul>\n<p>Though diabetes does not increase LDL levels, there is <strong>increased atherogenicity</strong> as the existing LDL molecules are more easily glycated and susceptible to oxidation. </p><p>The FDA recently approved Icosapent-ethyl, as an adjunctive to statin therapy to reduce the risk of cardiovascular events among adults with elevated triglyceride levels of 150 milligrams/dl or higher.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7081",
      "difficulty": "medium"
    },
    {
      "text": "Dyslipidemia is more commonly associated with which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Type 2 diabetes mellitus"
        },
        {
          "id": 2,
          "text": "Type 1 diabetes mellitus"
        },
        {
          "id": 3,
          "text": "Maturity onset diabetes of the young"
        },
        {
          "id": 4,
          "text": "Gestational diabetes mellitus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Dyslipidemia</strong> is more commonly associated with <strong>type 2 diabetes mellitus</strong>.</p>\n<p>It is less common in type 1 and gestational diabetes. Maturity onset diabetes of the young (MODY) is not associated with dyslipidemia.</p>\n<p>Note:&nbsp;<strong>Saroglitazar</strong> is a&nbsp;more advanced drug that <strong>reduces</strong> blood sugar and <strong>lipid levels</strong> in diabetic patients. It acts on PPAR alpha and gamma receptors.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7083",
      "difficulty": "easy"
    },
    {
      "text": "You have started a 40-year-old man on treatment for type 2 diabetes mellitus and dyslipidemia. Which of the following is not an appropriate target for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "HbA1c < 7 %"
        },
        {
          "id": 2,
          "text": "Blood pressure < 130 / 80 mmHg"
        },
        {
          "id": 3,
          "text": "Triglycerides < 150 mg/dL"
        },
        {
          "id": 4,
          "text": "Postprandial plasma glucose < 200 mg/dL"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>According to the ADA guidelines, a treatment goal of<strong>&nbsp;postprandial</strong>&nbsp;plasma glucose <strong>&lt; 180</strong> mg/dL must be followed in adults with diabetes.</p>\n<p>In <strong>younger</strong> individuals or those with other cardiovascular risk factors, the target blood pressure is <strong>&lt; 130/80</strong> <strong>mm Hg</strong>. Although not a treatment goal, the ADA also recommends triglyceride levels be maintained at &lt; 150 mg/dl.</p>\n<p>Note:&nbsp;Saroglitazar is a&nbsp;more advanced drug that reduces blood sugar and lipid levels in diabetic patients. It acts on PPAR alpha and gamma receptors.</p><hr><h3>Related Pearl: Treatment Goals for Adults with Diabetes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Index</strong></p>\n</td>\n<td>\n<p><strong>Goal</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HbA1c*</p>\n</td>\n<td>\n<p>&lt; 7 %</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Preprandial capillary plasma glucose</p>\n</td>\n<td>\n<p>80&ndash;130 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Peak postprandial capillary plasma glucose</p>\n</td>\n<td>\n<p>&lt;180 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Blood pressure<sup>+</sup></p>\n</td>\n<td>\n<p>&lt; 140/80 mmHg</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Note that most diabetes associations recommend the target HbA1c must be individualized to the patient. A target of &lt;7% is reasonable in most individuals.</p>\n<p>+ Blood pressure: Harrison's 20th&nbsp; edition,(based on ADA) recommends the target blood pressure goal of &lt;140/90 mmHg for adults with diabetes. It further adds that for younger individuals the target blood pressure is &lt;130/80 mmHg. But the \"AHA/SPRINT TRIAL recommendations\" recommend that the goal of blood pressure in patients with diabetes mellitus is less than <span class=\"nowrap\">130/80</span> mmHg.</p>\n<p>Dyslipidemia: Although not a treatment goal, ADA recommends&nbsp;to intensify lifestyle therapy and optimize glycemic control for patients with elevated triglyceride levels (&ge;150 mg/dL [1.7 mmol/L]) and/or low HDL cholesterol (&lt;40 mg/dL for men, &lt;50 mg/dL&nbsp; for women). Treatment with statins would depend on the overall cardiovascular risk (ASCVD) rather than specific LDL/HDL cholesterol level.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7087",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged patient with type 2 diabetes is diagnosed with essential hypertension. What is the antihypertensive drug of choice?",
      "choices": [
        {
          "id": 1,
          "text": "Losartan"
        },
        {
          "id": 2,
          "text": "Hydrochlorothiazide"
        },
        {
          "id": 3,
          "text": "Atenolol"
        },
        {
          "id": 4,
          "text": "Amlodipine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The drug of choice in this diabetic patient with hypertension is <strong>losartan.</strong></p>\n<p>Angiotensin-converting enzyme inhibitors (<strong>ACE inhibitors</strong>) or<strong>&nbsp;</strong>angiotensin&nbsp;receptor blockers (<strong>ARB</strong>) are the first-line drugs in diabetic hypertensives.&nbsp;Among ARBs, the drug of choice is <strong>telmisartan</strong> (acts on PPAR receptor).&nbsp;</p>\n<p>They reduce both macrovascular and microvascular complications and have a <strong>nephroprotective</strong> effect. However, they are <strong>contraindicated</strong> in <strong>chronic kidney</strong> <strong>disease&nbsp;</strong>as they can cause a further decline in GFR.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7091",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the earliest manifestation of diabetic nephropathy?",
      "choices": [
        {
          "id": 1,
          "text": "Microalbuminuria"
        },
        {
          "id": 2,
          "text": "Increased glomerular filtration rate"
        },
        {
          "id": 3,
          "text": "Decreased glomerular filtration rate"
        },
        {
          "id": 4,
          "text": "Increased urine PCR"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>earliest </strong>manifestation of diabetic nephropathy is an&nbsp;<strong>increase</strong>&nbsp;in the<strong>&nbsp;</strong>glomerular filtration rate (<strong>GFR</strong>).</p>\n<p>It occurs as a result of glomerular hyperperfusion and renal hypertrophy.&nbsp;The following sequence of changes are seen in diabetic nephropathy:</p>\n<ul>\n<li><strong>Increased GFR&nbsp;</strong></li>\n<li>Incipient diabetic nephropathy - <strong>microalbuminuria</strong> (30&ndash;300 mg/day albumin)\n<ul>\n<li>Diagnostic marker&nbsp;to detect early diabetic nephropathy</li>\n<li>Indicator of long-term cardiovascular disease</li>\n</ul>\n</li>\n<li>Overt diabetic nephropathy - <strong>macroalbuminuria</strong> ( &gt;300 mg/day albumin)</li>\n<li><strong>End-stage renal disease</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/10dc64a62ec7458781b3d41028a48f9ex1280x1772.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Chronic Complications of Type2 DM</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>Vascular</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microvascular</strong></p>\n</td>\n<td>\n<p><strong>Macrovascular</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Retinopathy</p>\n<p>Macular edema</p>\n</td>\n<td>\n<p>Coronary heart disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nephropathy</p>\n</td>\n<td>\n<p>Peripheral arterial disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuropathy</p>\n</td>\n<td>\n<p>Cerebrovascular disease</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p><strong>Non Vascular</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Gastrointestinal (gastroparesis, diarrhea)</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Genitourinary (uropathy/sexual dysfunction)</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Dermatologic</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Infectious</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Cataracts</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Glaucoma</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Cheiroarthropathy</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Periodontal disease</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Hearing loss</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7125",
      "difficulty": "medium"
    },
    {
      "text": "A 15-year-old boy has been on treatment for type 1 diabetes mellitus since the age of 10 years. His physician decides to begin screening for diabetic nephropathy. Which of the following is not always a reliable indicator of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Long duration of diabetes"
        },
        {
          "id": 2,
          "text": "Albuminuria of 30-300 mg/day"
        },
        {
          "id": 3,
          "text": "Presence of diabetic retinopathy"
        },
        {
          "id": 4,
          "text": "Reduced glomerular filtration rate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Albumin of 30-300 mg/day refers to <strong>microalbuminuria</strong>. It can be<strong>&nbsp;unreliable </strong>in the<strong>&nbsp;</strong>diagnosis&nbsp;of&nbsp;<strong>diabetic</strong> <strong>nephropathy</strong>.</p>\n<p>It is not required to diagnose nephropathy as it is very variable. <strong>Non-albuminuric</strong> diabetic nephropathy may occur in some patients and <strong>regression</strong> of albuminuria may be seen in type 1 diabetics.</p>\n<p>Diabetic nephropathy can be diagnosed if the following are satisfied:&nbsp;</p>\n<ul>\n<li><strong>Reduced</strong> <strong>GFR</strong> (&lt;&nbsp;60 mL/min/1.73 m<sup>2)&nbsp;</sup>with or without persistent albuminuria (&gt; 30 mg/day or urine PCR &gt; 30 mg/g)</li>\n<li>Long duration of diabetes or established diabetic retinopathy</li>\n<li>Other etiologies are ruled out</li>\n</ul>\n<p><strong>Long duration</strong> in<strong> type 1</strong> diabetes refers to <strong>5 years</strong> after diagnosis. On the other hand, patients with <strong>type 2</strong> diabetes are exposed to hyperglycemia and prediabetes for a long time even before diagnosis. Hence,&nbsp;at the <strong>time of diagnosis</strong>, patients with type 2 diabetes are considered to have had the disorder for a duration sufficiently long to produce kidney disease.</p>\n<p>However, a clinical diagnosis of diabetic nephropathy can be made in patients with established <strong>retinopathy</strong>, even if the duration of diabetes is short.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7127",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements about diabetic nephropathy is true?",
      "choices": [
        {
          "id": 1,
          "text": "Pancreatic transplantation can improve proteinuria at an early stage"
        },
        {
          "id": 2,
          "text": "Strict glycemic control is unlikely to prevent microalbuminuria"
        },
        {
          "id": 3,
          "text": "Dietary protein restriction can benefit diabetic patients with albuminuria"
        },
        {
          "id": 4,
          "text": "Microalbuminuria is not an indicator of long-term cardiovascular morbidity"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pancreatic&nbsp;</strong><strong>transplantation </strong>can help improve proteinuria at an early stage.&nbsp;Successful pancreatic transplantation can have the following effects:</p>\n<ul>\n<li><strong>Prevention</strong> of diabetic <strong>nephropathy</strong> and regression of albuminuria in early stages.</li>\n<li><strong>Stabilization</strong> and improvement of diabetic <strong>neuropathy</strong> and <strong>retinopathy</strong></li>\n<li>Increase in HDL with reduction in LDL and triglycerides</li>\n</ul>\n<p>Option B:&nbsp;Strict glycemic control can prevent or revert microalbuminuria.</p>\n<p>Option C:&nbsp;The ADA does not suggest restrictions of protein intake in diabetic&nbsp;patients with albuminuria because studies have failed to prove its benefits.</p>\n<p>Option D:&nbsp;Microalbuminuria is an indicator of long-term cardiovascular morbidity.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7128",
      "difficulty": "hard"
    },
    {
      "text": "A 50-year-old man with type 2 diabetes mellitus is found to have a 24-hour urinary albumin of 250 mg. Which of the following drugs may be prescribed to reduce the progression of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Hydrochlorothiazide"
        },
        {
          "id": 2,
          "text": "Enalapril"
        },
        {
          "id": 3,
          "text": "Amiloride"
        },
        {
          "id": 4,
          "text": "Eplerenone"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Angiotensin-converting enzyme (<strong>ACEI</strong>) inhibitors or angiotensin-receptor blockers (<strong>ARB</strong>)&nbsp;are recommended to reduce the progression of <strong>diabetic</strong> <strong>nephropathy</strong>. It has the following effects:</p>\n<ul>\n<li>Reduction of albuminuria</li>\n<li>Reduces the associated decline in GFR&nbsp;</li>\n</ul>\n<p>The mainstay of management of diabetic nephropathy includes control of blood sugar and blood pressure, inhibitors of the renin-angiotensin-aldosterone(RAAS) system, and inhibitors of SGLT2 to halt the progression of the disease.&nbsp;</p>\n<p>RAAS inhibitors include&nbsp;ACE inhibitors, ARBs, or direct renin inhibitors.</p><p>Recently, the FDA approved <strong>finerenone,</strong> a nonsteroidal mineralocorticoid receptor antagonist, to reduce the risk of sustained eGFR decline, end-stage renal disease, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in patients with chronic kidney disease (CKD) associated with type 2 diabetes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7130",
      "difficulty": "medium"
    },
    {
      "text": "A pathologist is studying a renal biopsy sample from a patient with suspected diabetic nephropathy. Which of the following biopsy findings is pathognomonic for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Diffuse glomerulosclerosis"
        },
        {
          "id": 2,
          "text": "Nodular glomerulosclerosis"
        },
        {
          "id": 3,
          "text": "Armani-Ebstein reaction"
        },
        {
          "id": 4,
          "text": "Basement membrane thickening"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>characteristic</strong> lesion of diabetic nephropathy is <strong>nodular </strong>or<strong>&nbsp;intercapillary&nbsp;</strong>glomerulosclerosis, also called&nbsp;<strong>Kimmelstiel-Wilson</strong> nodules.&nbsp;It is <strong>pathognomonic</strong> for this condition.</p>\n<p>The following image shows Kimmelstiel-Wilson nodules.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/53742981e810484a995a69d417426a9fx720x491.JPEG\" alt=\"Explanation Image\"><p>Other non-specific findings seen on biopsy include:</p>\n<ul>\n<li>Glomerular basement membrane (<strong>GBM</strong>)&nbsp;<strong>thickening</strong> - highly sensitive</li>\n<li><strong>Diffuse glomerulosclerosis</strong> -&nbsp;most common pattern, due to diffuse mesangial thickening</li>\n<li>Fibrin cap -&nbsp;accumulation of hyaline material within the&nbsp;capillary loop</li>\n<li>Capsular drop - accumulation of hyaline material attached to the&nbsp;Bowman's capsule&nbsp;</li>\n<li><strong>Armani-Ebstein</strong> reaction - collection of glycogen clumps within the renal tubules due to tubular injury</li>\n</ul>\n<p>Renal biopsy is done to rule out other causes of renal failure. The indications for renal biopsy in diabetic nephropathy are:</p>\n<ul>\n<li>Absence of diabetic retinopathy</li>\n<li>Absence of edema</li>\n<li>Absence of frothing and proteinuria</li>\n<li>Absence of hypertension</li>\n<li>Presence of microscopic hematuria or features of nephritic syndrome</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7132",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following types of renal tubular acidosis can develop in individuals with diabetes mellitus?",
      "choices": [
        {
          "id": 1,
          "text": "Type I RTA"
        },
        {
          "id": 2,
          "text": "Type II RTA"
        },
        {
          "id": 3,
          "text": "Type III RTA"
        },
        {
          "id": 4,
          "text": "Type IV RTA"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Type IV </strong>renal tubular acidosis (<strong>RTA</strong>) may occur in individuals with <strong>diabetes</strong> mellitus types 1 and 2.</p>\n<p>Type IV RTA occurs due to <strong>hyporeninemic</strong> <strong>hypoaldosteronism</strong>.&nbsp;Low plasma renin activity is common in diabetic patients due to:</p>\n<ul>\n<li>Impaired conversion of prorenin to renin</li>\n<li>Volume expansion in diabetic nephropathy suppresses renin release</li>\n</ul>\n<p>These individuals have a tendency to develop&nbsp;<strong>hyperkalemia</strong> and <strong>acidemia</strong>, which can be <strong>exacerbated</strong> by the use of <strong>ACEI</strong> and <strong>ARBs</strong>.&nbsp;Hence, these drugs should be avoided.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7134",
      "difficulty": "hard"
    },
    {
      "text": "A 45-year-old man has been diagnosed with type 2 diabetes mellitus. When should you refer him to an ophthalmologist?",
      "choices": [
        {
          "id": 1,
          "text": "Within one year of diagnosis"
        },
        {
          "id": 2,
          "text": "Immediately at the time of diagnosis"
        },
        {
          "id": 3,
          "text": "Within five years of diagnosis"
        },
        {
          "id": 4,
          "text": "Within three years of diagnosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Patients with <strong>type 2</strong> diabetes should undergo a comprehensive <strong>ophthalmological</strong> <strong>examination</strong> to screen for diabetic retinopathy <strong>at diagnosis</strong>,&nbsp;followed by an <strong>annual</strong>&nbsp;examination of the <strong>fundus</strong>.</p>\n<p>In patients with <strong>type 1</strong> diabetes mellitus, screening for retinopathy is recommended&nbsp;<strong>3 to 5&nbsp;years </strong>after diagnosis.&nbsp;Annual fundal examination&nbsp;is recommended thereafter.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7136",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following patients would you screen for diabetic retinopathy?<div class='question-desc-html'><ol>\n<li>A 10-year-old boy on treatment for type 1 diabetes for the past 2 years</li>\n<li>A 48-year-old man newly diagnosed with type 2 diabetes</li>\n<li>A 25-year-old primigravida with gestational diabetes mellitus</li>\n<li>A 62-year-old man with diabetic nephropathy</li>\n<li>A 22-year-old woman with prepubertal onset of type 1 diabetes</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 4, 5"
        },
        {
          "id": 2,
          "text": "1, 4, 5"
        },
        {
          "id": 3,
          "text": "2, 3, 5"
        },
        {
          "id": 4,
          "text": "1, 2, 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Screening</strong> for <strong>diabetic retinopathy</strong> is done at <strong>3-5 years</strong> following diagnosis in<strong> type 1</strong> diabetes mellitus, whereas, patients with <strong>type 2</strong> diabetes must be screened <strong>at the time of diagnosis.</strong></p>\n<p>As type 2 diabetes mellitus often has a long <strong>asymptomatic</strong> period of <strong>hyperglycemia</strong> before clinical diagnosis, these patients are more likely to have complications at the time of diagnosis itself.</p>\n<p>Retinopathy develops in nearly 50-80% of patients by 20 years of diagnosis. The presence of diabetic retinopathy often correlates with pathological findings of diabetic nephropathy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7141",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common clinical presentation of diabetic neuropathy?",
      "choices": [
        {
          "id": 1,
          "text": "Autonomic neuropathy"
        },
        {
          "id": 2,
          "text": "Mononeuropathy"
        },
        {
          "id": 3,
          "text": "Distal polyneuropathy"
        },
        {
          "id": 4,
          "text": "Polyradiculopathy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>most common</strong> form of diabetic neuropathy is <strong>distal symmetric polyneuropathy.</strong> It presents with distal sensory loss and pain in a stocking-and-glove distribution and is a risk factor for foot ulceration.</p>\n<p><strong>Autonomic</strong> <strong>neuropathy</strong> is a common complication and results in the following features:</p>\n<ul>\n<li>Postural hypotension</li>\n<li>Silent myocardial infarction</li>\n<li>Hypoglycemia unawareness</li>\n<li>Erectile dysfunction</li>\n<li>Overflow incontinence</li>\n<li>Gastroparesis</li>\n<li>Enteropathy with constipation or diarrhea</li>\n</ul>\n<p><strong>Mononeuropathy</strong> of <strong>peripheral</strong> (median, ulnar, radial) and cranial (<strong>oculomotor</strong>) nerves is also seen, as well as mononeuritis multiplex.</p>\n<p>Diabetic <strong>polyradiculopathy</strong> is characterized by severe pain along the distribution of one or more <strong>nerve roots</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7146",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following findings in a diabetic patient is self-limiting?",
      "choices": [
        {
          "id": 1,
          "text": "Macular edema"
        },
        {
          "id": 2,
          "text": "Peripheral neuropathy"
        },
        {
          "id": 3,
          "text": "Amyotrophy"
        },
        {
          "id": 4,
          "text": "Macroalbuminuria"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Amyotrophy</strong> refers to <strong>weakness</strong> of <strong>hip extensors</strong> and <strong>flexors</strong> secondary to polyradiculopathy involving the lumbar plexus and femoral nerve. It is associated with severe <strong>pain</strong> along the distribution of the nerve roots. It is <strong>self-limiting</strong> and resolves over 6-12 months.</p>\n<p>Strict glycemic control can reduce the incidence and prevent the progression of macular edema, peripheral neuropathy, and macroalbuminuria. However, once developed, they cannot be reversed. Intermittent microalbuminuria with normal GFR can be reversed with strict glycemic control.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7144",
      "difficulty": "hard"
    },
    {
      "text": "You are evaluating a 65-year-old diabetic woman who has been admitted following a seizure. On admission, she was unconscious, and random blood glucose at admission was 37 mg/dl. The hypoglycemia was corrected and she regained consciousness. The woman says that she had felt normal and had no other symptoms prior to the onset of seizures. What is the likely cause of this presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Medication change from metformin to insulin"
        },
        {
          "id": 2,
          "text": "Insulin resistance"
        },
        {
          "id": 3,
          "text": "Autonomic neuropathy"
        },
        {
          "id": 4,
          "text": "Concurrent use of thiazide diuretics"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This clinical scenario is suggestive of <strong>silent hypoglycemia </strong>in a diabetic patient. The most likely cause is <strong>autonomic neuropathy</strong>.</p>\n<p>Hypoglycemia presents with symptoms like <strong>palpitation, tremors, </strong>and<strong> sweating</strong> as a result of&nbsp;sympathetic stimulation.&nbsp;These symptoms are <strong>protective </strong>and provide advance warning before progression to neuroglucopenia.</p>\n<p>However, in autonomic neuropathy, there is a&nbsp;<strong>reduced&nbsp;</strong>release of counterregulatory hormones like&nbsp;<strong>catecholamines.</strong>&nbsp;Hence, the classical symptoms of hypoglycemia do not occur and the patient directly presents with features of neuroglucopenia. This is called <strong>hypoglycemia unawareness</strong>.</p>\n<p>The use of <strong>beta-blockers</strong> can also cause hypoglycemia unawareness.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7149",
      "difficulty": "medium"
    },
    {
      "text": "You are counselling a patient with longstanding, poorly-controlled diabetes mellitus. Advising tight glycemic control in this patient would not improve which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Neuropathy"
        },
        {
          "id": 2,
          "text": "Retinopathy"
        },
        {
          "id": 3,
          "text": "Peripheral vascular disease"
        },
        {
          "id": 4,
          "text": "Nephropathy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In patients with <strong>longstanding</strong> <strong>diabetes</strong> mellitus, <strong>tight</strong> <strong>glycaemic</strong> <strong>control</strong> is beneficial for<strong>&nbsp;</strong>microvascular complications. However, it has <strong>no effect </strong>on <strong>macrovascular</strong> complications like peripheral vascular disease (PVD), myocardial infarction, and stroke.</p>\n<p>Good glycemic control improves microvascular complications through&nbsp;<strong>primary</strong> and <strong>secondary</strong> <strong>prevention</strong>. It reduces the incidence of complications as well as stabilizes and prevents further progression in affected individuals.&nbsp;Intermittent microalbuminuria with normal GFR can even be reversed with tight glycemic control.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Complication</strong></p>\n</td>\n<td>\n<p><strong>% risk reduction with tight glycemic control</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Retinopathy</p>\n</td>\n<td>\n<p>47 %</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Microalbuminuria</p>\n</td>\n<td>\n<p>39 %</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nephropathy</p>\n</td>\n<td>\n<p>54%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuropathy</p>\n</td>\n<td>\n<p>60 %</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7150",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following statements explains Legacy effect and metabolic memory?<div class='question-desc-html'><ol>\n<li>Intensive glycemic control in early disease</li>\n<li>Early detection and management of dyslipidemia</li>\n<li>Good glycemic control in longstanding disease</li>\n<li>High HbA1c values in longstanding disease</li>\n<li>Uncontrolled blood glucose levels in early disease</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 5"
        },
        {
          "id": 2,
          "text": "1 and 2"
        },
        {
          "id": 3,
          "text": "2 and 3"
        },
        {
          "id": 4,
          "text": "4 and 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Legacy effect</strong> or <strong>metabolic memory</strong> can be observed in relation to <strong>glycemic control</strong> during <strong>early disease</strong> in patients with diabetes mellitus.</p>\n<p><strong>Intensive glycemic control</strong> during the early stages of the disease has a positive effect on long-term <strong>microvascular</strong> and <strong>macrovascular</strong> complications (statement 1) even if this intensive glycemic control is not maintained long term. Similarly, <strong>uncontrolled blood glucose</strong> levels in the early stages causes an increased risk of these complications (statement 5). This phenomenon is called legacy effect and is attributed to metabolic memory. </p>\n<p>In patients with <strong>longstanding</strong> diabetes, intensive glycemic control at later stages can improve <strong>microvascular</strong> complications but has no effect on macrovascular complications.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7114",
      "difficulty": "hard"
    },
    {
      "text": "A patient with chronic diabetes presents to the OPD for his annual checkup. A small painless ulcer is noted over his right foot. His BMI is 33 kg/m2. All of the following factors can be implicated in the causation of his foot ulcer except:",
      "choices": [
        {
          "id": 1,
          "text": "Venous stasis"
        },
        {
          "id": 2,
          "text": "Neuropathy"
        },
        {
          "id": 3,
          "text": "Immunosuppression"
        },
        {
          "id": 4,
          "text": "Ischemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Venous stasis is not a cause of <strong>diabetic foot ulcers </strong>and&nbsp;gangrene. They are usually caused by a combination of three factors:</p>\n<ul>\n<li><strong>Ischemia</strong>&nbsp;- secondary to atheroma</li>\n<li><strong>Peripheral neuropathy</strong> - leads to trophic skin changes</li>\n<li><strong>Immunosuppression</strong> - due to excess sugar deposition in tissues, predisposing diabetic patients to infection</li>\n</ul>\n<p>Common sites&nbsp;of ulcers include:</p>\n<ul>\n<li>Great toe</li>\n<li>Metatarsophalangeal areas.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7152",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old diabetic woman presents to the OPD with the following skin lesions. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Necrolytic migratory erythema"
        },
        {
          "id": 2,
          "text": "Diabetic dermopathy"
        },
        {
          "id": 3,
          "text": "Necrobiosis lipoidica"
        },
        {
          "id": 4,
          "text": "Granuloma annulare"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given image showing irregular plaques with yellowish discoloration and telangiectasias are suggestive of&nbsp;<strong>necrobiosis lipoidica diabeticorum.</strong></p>\n<p>It is an inflammatory granulomatous disorder of the skin due to <strong>collagen degeneration</strong> and <strong>lipid </strong>deposition. It is usually seen in young women with diabetes mellitus.</p>\n<p>The lesions usually begin in the <strong>pretibial</strong> region. It begins as papules that gradually enlarge and darken to form erythematous plaques with irregular margins,&nbsp;<strong>atrophic centers,</strong> and central ulceration.</p>\n<p>Option A: <strong>Necrolytic migratory erythema</strong> is a feature of <strong>glucagonoma.</strong> It is a waxing and waning rash that appears as shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/27f35b60e1a04d2ea9b5a157ae9a51bex720x468.PNG\" alt=\"Explanation Image\"><p>Option B: <strong>Diabetic dermopathy</strong> or shin spots are commonly seen in elderly men. It presents as <strong>pigmented pretibial papules</strong> as shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ce26f3db7f14420585c1ad9b6e2875f6x720x540.PNG\" alt=\"Explanation Image\"><p>Option D: <strong>Granuloma annulare</strong> presents with <strong>small papules</strong> arranged in an <strong>annular</strong> pattern. There is no yellowish discoloration or telangiectasias, as shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4330817c3e804fae84488637beed43fcx399x599.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/98efa019b5634ea1ae597f1bc962b36f.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7156",
      "difficulty": "medium"
    },
    {
      "text": "Patients with diabetes mellitus are at a higher risk of developing all of the following infections except:",
      "choices": [
        {
          "id": 1,
          "text": "Malignant otitis externa"
        },
        {
          "id": 2,
          "text": "Rhinocerebral mucormycosis"
        },
        {
          "id": 3,
          "text": "Emphysematous pyelonephritis"
        },
        {
          "id": 4,
          "text": "Emphysematous appendicitis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Emphysematous appendicitis</strong> is not a complication of diabetes mellitus.&nbsp;The&nbsp;potentially fatal&nbsp;infectious <strong>complications</strong> of <strong>diabetes</strong> include:</p>\n<ul>\n<li>Malignant otitis externa</li>\n<li>Rhinocerebral mucormycosis</li>\n<li>Emphysematous pyelonephritis&nbsp;</li>\n<li>Emphysematous cholecystitis</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7158",
      "difficulty": "medium"
    },
    {
      "text": "A morbidly obese diabetic woman is not responsive to metformin therapy. She has a history of pancreatitis and family history of bladder cancer. She does not want to take injections. Which of the following would be suitable to reduce her glucose levels?",
      "choices": [
        {
          "id": 1,
          "text": "Sitagliptin"
        },
        {
          "id": 2,
          "text": "Pioglitazone"
        },
        {
          "id": 3,
          "text": "Canagliflozin"
        },
        {
          "id": 4,
          "text": "Liraglutide"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Among the given options, <strong>canagliflozin</strong> (Option C) is the most <strong>suitable treatment</strong>. It is an <strong>oral drug</strong> belonging to the class <strong>SGLT-2 inhibitors</strong> and causes <strong>weight loss</strong>. Although it increases the risk of urogenital infections, it has <strong>no risk</strong> of <strong>pancreatitis</strong> or <strong>bladder cancer</strong>.</p>\n<p>Option A: <strong>Sitagliptin</strong>, a DPP-IV inhibitor, is associated with the risk of <strong>acute pancreatitis</strong>.</p>\n<p>Option B: <strong>Pioglitazone</strong>, a thiazolidinedione, can increase the risk of <strong>bladder cancer</strong> and can cause weight gain and <strong>congestive cardiac failure</strong>.</p>\n<p>Option D: <strong>Liraglutide</strong> is an injectable GLP-1 receptor agonist. <strong>Pancreatitis</strong> is a serious adverse effect of this drug. Hence, it is contraindicated in individuals with a history of pancreatitis and should be permanently discontinued if pancreatitis develops.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9260",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following anti-diabetic drugs should be stopped in a patient with a creatinine of 5.6 mg/dL?",
      "choices": [
        {
          "id": 1,
          "text": "Metformin"
        },
        {
          "id": 2,
          "text": "Linagliptin"
        },
        {
          "id": 3,
          "text": "Metoprolol"
        },
        {
          "id": 4,
          "text": "Insulin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Metformin</strong> should be <strong>stopped</strong> in case of <strong>elevated creatinine levels</strong> (renal insufficiency) <strong>&gt; 1.5 mg/dl in men</strong> and <strong>&gt;1.4 mg/dl in women</strong>.</p>\n<p>Metformin acts by <strong>reducing hepatic glucose production</strong> and <strong>improves peripheral glucose utilization</strong>. Lactic acidosis and Vitamin B12 deficiency are specific adverse effects of metformin. It is <strong>not</strong> used in patients with a&nbsp;<strong>glomerular filtration rate &lt;30 mL/min&nbsp;</strong>(moderate renal insufficiency), acidosis, unstable congestive cardiac failure, liver disease, severe hypoxemia, and patients undergoing contrast studies.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9265",
      "difficulty": "easy"
    }
  ]
}